EF
MEDP icon

Empowered Funds’s Medpace MEDP Stock Holding History

Empowered Funds’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.3M Sell
23,171
-2,559
-10% -$1.18M 0.06% 341
2026
Q1 		$12.4M Buy
25,730
+6,113
+31% +$3.13M 0.08% 293
2025
Q4 		$11M Buy
19,617
+1,780
+10% +$1.01M 0.19% 113
2025
Q3 		$9.17M Sell
17,837
-2,554
-13% -$1.12M 0.09% 255
2025
Q2 		$6.4M Buy
20,391
+11,941
+141% +$3.58M 0.07% 371
2025
Q1 		$2.57M Sell
8,450
-243
-3% -$81.7K 0.04% 622
2024
Q4 		$2.89M Buy
8,693
+2,130
+32% +$722K 0.04% 570
2024
Q3 		$2.19M Sell
6,563
-9,493
-59% -$3.61M 0.03% 645
2024
Q2 		$6.61M Buy
16,056
+703
+5% +$278K 0.11% 233
2024
Q1 		$6.2M Buy
15,353
+10,941
+248% +$3.85M 0.11% 256
2023
Q4 		$1.35M Sell
4,412
-4,213
-49% -$1.14M 0.03% 659
2023
Q3 		$2.09M Buy
8,625
+178
+2% +$45.5K 0.06% 438
2023
Q2 		$2.03M Buy
8,447
+346
+4% +$71.9K 0.07% 389
2023
Q1 		$1.52M Buy
+8,101
New +$1.68M 0.09% 233
2022
Q4 		– Sell
-3,047
Closed -$609K – 529
2022
Q3 		$479K Buy
+3,047
New +$486K 0.05% 254

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Empowered Funds's MEDP Position: Q2 2026 in Review

Empowered Funds reduced its Medpace (MEDP) stake by 9.9% in Q2 2026, selling an estimated $1.18M and leaving 23,171 shares worth $12.3M. The position accounts for 0.06% of the portfolio, ranked #341.

Empowered Funds first reported a position in MEDP in Q3 2022 and has held it in 15 quarters since. The position peaked at $12.4M in Q1 2026. 695 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Empowered Funds held 23,171 shares of Medpace worth $12.3M as of Q2 2026.
  • Empowered Funds sold 2,559 Medpace shares in Q2 2026, an estimated $1.18M.
  • Medpace made up 0.06% of Empowered Funds's portfolio in Q2 2026, its #341 holding.
  • Empowered Funds first reported a position in Medpace in Q3 2022 and has held it in 15 quarters since.
  • Empowered Funds's Medpace position peaked at $12.4M in Q1 2026.
  • 695 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Empowered Funds's 13F filing for Q2 2026, filed 17 Aug 2026.